Zevra Therapeutics Stock (NASDAQ: ZVRA) stock price, news, charts, stock research, profile.
Open | $7.31 |
Close | $7.18 |
Volume / Avg. | 421.46K / 715.52K |
Day Range | $7.11 - $7.39 |
52 Wk Range | 3.89 - 8.44 |
Market Cap | $379.90M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 57 |
Short Interest | 8.39% |
Days to Cover | 5.2 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Zevra Therapeutics (NASDAQ:ZVRA) through any online brokerage.
Other companies in Zevra Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Theravance Biopharma (NASDAQ:TBPH), Third Harmonic Bio (NASDAQ:THRD), GH Research (NASDAQ:GHRS) and SNDL (NASDAQ:SNDL).
Zevra Therapeutics has a consensus price target of $18.75.
The stock price for Zevra Therapeutics (NASDAQ: ZVRA) is $7.22 last updated August 23, 2024 at 5:35 PM EDT.
There are no upcoming dividends for Zevra Therapeutics.
Zevra Therapeutics’s Q3 earnings are confirmed for Tuesday, November 5, 2024.
There is no upcoming split for Zevra Therapeutics.
Zevra Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.